Showing 4751-4760 of 7004 results for "".
- Scientists: Obesity Battle Extends Beyond Lifestyle Changeshttps://reachmd.com/news/scientists-obesity-battle-extends-beyond-lifestyle-changes/2463215/Anti-obesity drugs such as Ozempic were the "breakthrough of the year" in 2023, according to the AAAS journal Science. Overweight and obesity rates are rising worldwide, with several Latin American countries in the forefront. Estimates for 2020 pointed to a global obesity rate of 1
- HSS Launches Clinical Trial to Address Post-Traumatic Osteoarthritis After ACL Revision Surgeryhttps://reachmd.com/news/hss-launches-clinical-trial-to-address-post-traumatic-osteoarthritis-after-acl-revision-surgery/2463151/Randomized Clinical Trial to Explore the Efficacy of Concentrated Bone Marrow Aspirate as an Addition to ACL Revision Surgery NEW YORK, May 20, 2024 /PRNewswire/ — Up to 18% of patients undergoing ACL reconstruction experience graft failure
- Dermavant Publishes ADORING 1 & ADORING 2 Phase 3 Trial Results for Vtama Cream for ADhttps://reachmd.com/news/dermavant-publishes-adoring-1-adoring-2-phase-3-trial-results-vtama-cream-ad/2463173/Dermavant Sciences announced that the data from ADORING 1 and ADORING 2 phase 3 trials of Vtama (tapinarof) cream 1% for adults and children 2 years of age and older with atopic dermatitis (AD) has been published in the Journal of the American Academy of Dermatology. Vtama cream i
- Scientists Use New Approach to Disable Brain Cancer Cell's Ability to Survivehttps://reachmd.com/news/scientists-use-new-approach-to-disable-brain-cancer-cells-ability-to-survive/2463115/The mTORC1 substrates 4EBP1/2 prevent cell death in response to glucose starvation in human, mouse and yeast cells. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-48
- Sports Drink Myths Bustedhttps://reachmd.com/news/sports-drink-myths-busted/2463106/Sports drink companies sell consumers a dream. They have convinced the world that a bottle of their product can work wonders for the body and provide numerous health benefits. Many consumers believe that sports drinks keep you hydrated, boost the electrolytes in your body, improve your
- Is There a Certain Smell Linked to Parkinson’s?https://reachmd.com/news/is-there-a-certain-smell-linked-to-parkinsons/2463094/Parkinson’s causes the production of an oily substance on your skin, resulting in a particular scent, but it’s usually not noticeable. However, a reduced sense of smell in people with Parkinson’s may affect their ability to detect their odor.<
- Mental Health Podcasts: Sharing Stories, Reducing Stigmahttps://reachmd.com/news/mental-health-podcasts-sharing-stories-reducing-stigma/2463083/It’s often said that podcasting is a very intimate medium. It's like listening to a friend or friends talk to you, and you alone. Podcasts can be entertaining, educational, even comforting. For some people, they’re almost therapeutic. Mental health podcasts are no different, and in fac
- Study Discovers Distinct Population of 'Troublemaker' Platelet Cells Appear with Aginghttps://reachmd.com/news/study-discovers-distinct-population-of-troublemaker-platelet-cells-appear-with-aging/2463050/Upon vascular injury, platelets in young mice form much smaller blood clots (left) than platelets in old mice (right), where the clot almost occludes the blood vessel. Fluorescence microscop
- Transgender Preteens Log 13-Hour Daily Screen Timehttps://reachmd.com/news/transgender-preteens-log-13-hour-daily-screen-time/2463039/Toronto, ON - A new national study found that transgender preteens, 12 and13 years old, reported 13 hours of daily recreational screen time, which was 4.5 hours more than their cisgender peers. Data were collected from 2019 to 2021, overlapping with the COVID-19 pandemic, and the s
- Regenex Bio Eyes FDA Meeting to Confirm Pivotal DMD Trialhttps://reachmd.com/news/regenex-bio-eyes-fda-meeting-to-confirm-pivotal-dmd-trial/2463008/Regenex Bio has announced it is meeting with the US Food and Drug Administration (FDA) with plans to initiate a pivotal trial of its Duchenne muscular dystrophy (DMD) gene therapy candidate before the end of this year. The US-based biotech is looking to investigate its